Stock News
Bloomin’ Brands Bummer: Stock Dips as Revenue Misses the Mark for the Sixth Quarter in a Row – Ouch!
Outback Steakhouse’s Parent Company Reports Loss, Offers Cautious 2025 Guidance: What Does It Mean for You and the World? In a recent financial report, the parent company of Outback Steakhouse, Bloomin’ Brands, announced a loss for the second quarter of 2022. The company, which also owns Carrabba’s Italian Grill, Bonefish Grill, and Fleming’s Prime Steakhouse…
Kyowa Kirin Unveils Exciting New Research at the American Academy of Dermatology Meeting 2025
Kyowa Kirin’s Latest Breakthrough: A Game Changer in Cancer Treatment Princeton, N.J. – Kyowa Kirin Co., Ltd., a leading research-based life sciences company, recently announced a significant breakthrough in cancer treatment. The company’s researchers have developed a novel therapeutic antibody, KK-41, which has shown promising results in eliminating cancer cells in preclinical trials. About KK-41…
Get Ready for ABM’s Quirky Q1 2025 Financial Results Announcement: A Playful Peek into the Numbers!
ABM’s Q1 2025 Financial Results Announcement: What Does It Mean for You and the World? New York, February 26, 2025 – ABM, a distinguished provider of facility solutions, recently declared that they will be sharing their financial results for the first quarter of their fiscal year 2025. This announcement comes with an expected release date…
PDS Biotech Reports Encouraging Clinical Data: Survival and Response Improvements in Recurrent HPV-Linked Cancers Published in JAMA Oncology
PDS Biotech Announces Publication of Clinical Results in JAMA Oncology: Impressive Survival and Response Rates in HPV16-Positive Cancers PDS Biotechnology Corporation, a pioneering immunotherapy company, recently announced the publication of clinical results in the esteemed Journal of the American Medical Association (JAMA) Oncology. These data showcase promising outcomes for HPV16-positive cancer patients treated with PDS…
Dr. Albert P. Garcia-Romeu Appointed as Chair of Psyence Biomed’s New Scientific Advisory Board
Psyence Biomedical and Albert P. Collaborate on Groundbreaking Research NEW YORK, Feb. 26, 2025 – Psyence Biomedical Ltd. (Nasdaq: PBM), a leading biotech company specializing in the research, development, and commercialization of innovative medicines, announced today a new collaboration with renowned scientist, Albert P., to advance their ongoing research in the field of neuroscience. About…
Peloton Stock: Can It Double in Value by 2030? An In-Depth Analysis
Peloton Interactive: Regaining Favor in the Investment Community In recent months, Peloton Interactive (PTON) has been making strides to improve its financial situation, leading to renewed interest from the investment community. After experiencing a significant decline in stock price, the company’s financial improvements have helped to reduce the perceived risk, making it an attractive prospect…
First Dose Administered in Assembly Biosciences’ Quirky Quest: A Humorous Look at the Beginning of the Clinical Trial Journey for ABI-6250, the Oral Hepatitis Delta Virus Entry Inhibitor
Exciting News from Assembly Biosciences: First Participant Dosed in ABI-6250 Phase 1a Trial In a recent press release, Assembly Biosciences, Inc. made an announcement that left the scientific community buzzing with excitement! The biotech company, known for its innovative therapeutics targeting serious viral diseases, has begun dosing the first participant in the Phase 1a trial…
Southwest Gas Holdings Inc. Reveals Q4 and Full Year 2024 Financial Results: An In-Depth Analysis
Southwest Gas Holdings Reports Fourth Quarter and Full-Year 2024 Financial Results Southwest Gas Holdings, Inc. recently announced its financial results for the fourth quarter and full-year ended December 31, 2024. The company reported a consolidated net income of $92.5 million, or $1.28 per diluted share, and an adjusted consolidated net income of $100.1 million, or…